Dose-ranging study of riluzole in amyotrophic lateral sclerosis
- 1 May 1996
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 347 (9013) , 1425-1431
- https://doi.org/10.1016/s0140-6736(96)91680-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Prognostic Factors and Survival in Amyotrophic Lateral SclerosisNeuroepidemiology, 1994
- Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytesEuropean Journal of Pharmacology, 1993
- Expression cloning of an epithelial amiloride‐sensitive Na+ channelFEBS Letters, 1993
- Duration of amyotrophic lateral sclerosis is age dependentMuscle & Nerve, 1993
- Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on d[3H]aspartate release from cultured cerebellar granule cellsNeuroscience Letters, 1992
- Survival prediction in amyotrophic lateral sclerosisMuscle & Nerve, 1989
- Estimation and Comparison of Changes in the Presence of Informative Right Censoring by Modeling the Censoring ProcessPublished by JSTOR ,1988
- Clinical Statistics in 515 Fatal Cases of Motor Neuron DiseaseNeuroepidemiology, 1984
- Tests for trend in life table analysisBiometrika, 1975